139 related articles for article (PubMed ID: 33586962)
1. Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin.
Baytas SN; Varghese SS; Jin W; Yu Y; He P; Douaisi M; Zhang F; Brodfuehrer P; Xia K; Dordick JS; Linhardt RJ
J Med Chem; 2021 Feb; 64(4):2242-2253. PubMed ID: 33586962
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.
Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ
Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753
[TBL] [Abstract][Full Text] [Related]
3. Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.
Masuko S; Linhardt RJ
Future Med Chem; 2012 Mar; 4(3):289-96. PubMed ID: 22393937
[TBL] [Abstract][Full Text] [Related]
4. Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.
Brieger D; Dawes J
Thromb Haemost; 1997 Feb; 77(2):317-22. PubMed ID: 9157589
[TBL] [Abstract][Full Text] [Related]
5. Search for the heparin antithrombin III-binding site precursor.
Linhardt RJ; Wang HM; Loganathan D; Bae JH
J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
Nagasawa K; Uchiyama H
J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
[TBL] [Abstract][Full Text] [Related]
8. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
9. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin.
Fu L; Li K; Mori D; Hirakane M; Lin L; Grover N; Datta P; Yu Y; Zhao J; Zhang F; Yalcin M; Mousa SA; Dordick JS; Linhardt RJ
J Med Chem; 2017 Oct; 60(20):8673-8679. PubMed ID: 28972371
[TBL] [Abstract][Full Text] [Related]
11. Novel method for measurement of heparin anticoagulant activity using SPR.
Zhao J; Liu X; Malhotra A; Li Q; Zhang F; Linhardt RJ
Anal Biochem; 2017 Jun; 526():39-42. PubMed ID: 28322799
[TBL] [Abstract][Full Text] [Related]
12. Filter-entrapment enrichment pull-down assay for glycosaminoglycan structural characterization and protein interaction.
Yu Y; Zhang F; Renois-Predelus G; Amster IJ; Linhardt RJ
Carbohydr Polym; 2020 Oct; 245():116623. PubMed ID: 32718661
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
Cesaretti M; Luppi E; Maccari F; Volpi N
Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
[TBL] [Abstract][Full Text] [Related]
15. Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo.
Schick BP; Maslow D; Moshinski A; San Antonio JD
Blood; 2004 Feb; 103(4):1356-63. PubMed ID: 14576044
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
[TBL] [Abstract][Full Text] [Related]
17. Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources.
Loganathan D; Wang HM; Mallis LM; Linhardt RJ
Biochemistry; 1990 May; 29(18):4362-8. PubMed ID: 2350542
[TBL] [Abstract][Full Text] [Related]
18. Novel approach for preparation of heparins specific to factor Xa using affinity chromatography coupled with synthetic antithrombin III-related peptides.
Onoue S; Harada S; Nemoto Y; Yajima T; Kashimoto K
Peptides; 2003 Jun; 24(6):821-6. PubMed ID: 12948833
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological activities of heparin chains: should our past knowledge be revised?
Agnelli G
Haemostasis; 1996; 26 Suppl 2():2-9. PubMed ID: 8707164
[TBL] [Abstract][Full Text] [Related]
20. Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin.
Fukuda T; Kamisato C; Honda Y; Matsushita T; Kojima T; Furugohri T; Morishima Y; Shibano T
Thromb Res; 2013 Jun; 131(6):540-6. PubMed ID: 23673387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
